Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively

A. J G Swaak, J. C. Nossent, W. Bronsveld, A. Van Rooyen, E. J. Nieuwenhuys, L. Theuns, R. J T Smeenk

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

This report presents an analysis of the cumulative survival in 110 well defined patients with systemic lupus erythematosus (SLE) who were followed up over a prolonged period of time. Special attention was paid to possible differences between patients who died and those who were still alive at the end of the study. Of the 110 patients with SLE, 96 (87%) were still alive after 10 years; the cumulative survival for men was 69% (11/16) and for women 90% (85/94). Patients who never developed a new exacerbation after the diagnosis for SLE had been established had a 10 year survival of 100%; for patients with one, two, or three exacerbations the 10 year survival was 91%, 69%, and 33% respectively. From these prospective studies it was found that the exacerbation frequency is most closely related to survival. Disease symptoms of renal involvement, or both, present at the onset or at the moment the SLE diagnosis was established, were predominantly seen in patients who died during the follow up.

Original languageEnglish
Pages (from-to)447-454
Number of pages8
JournalAnnals of the Rheumatic Diseases
Volume48
Issue number6
Publication statusPublished - 1989
Externally publishedYes

Fingerprint

Systemic Lupus Erythematosus
Survival
Survival Analysis
Prospective Studies
Kidney

Cite this

Swaak, A. J. G., Nossent, J. C., Bronsveld, W., Van Rooyen, A., Nieuwenhuys, E. J., Theuns, L., & Smeenk, R. J. T. (1989). Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Annals of the Rheumatic Diseases, 48(6), 447-454.
Swaak, A. J G ; Nossent, J. C. ; Bronsveld, W. ; Van Rooyen, A. ; Nieuwenhuys, E. J. ; Theuns, L. ; Smeenk, R. J T. / Systemic lupus erythematosus. I. Outcome and survival : Dutch experience with 110 patients studied prospectively. In: Annals of the Rheumatic Diseases. 1989 ; Vol. 48, No. 6. pp. 447-454.
@article{d16bb1ad16d64a13b41c0938956a6a33,
title = "Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively",
abstract = "This report presents an analysis of the cumulative survival in 110 well defined patients with systemic lupus erythematosus (SLE) who were followed up over a prolonged period of time. Special attention was paid to possible differences between patients who died and those who were still alive at the end of the study. Of the 110 patients with SLE, 96 (87{\%}) were still alive after 10 years; the cumulative survival for men was 69{\%} (11/16) and for women 90{\%} (85/94). Patients who never developed a new exacerbation after the diagnosis for SLE had been established had a 10 year survival of 100{\%}; for patients with one, two, or three exacerbations the 10 year survival was 91{\%}, 69{\%}, and 33{\%} respectively. From these prospective studies it was found that the exacerbation frequency is most closely related to survival. Disease symptoms of renal involvement, or both, present at the onset or at the moment the SLE diagnosis was established, were predominantly seen in patients who died during the follow up.",
author = "Swaak, {A. J G} and Nossent, {J. C.} and W. Bronsveld and {Van Rooyen}, A. and Nieuwenhuys, {E. J.} and L. Theuns and Smeenk, {R. J T}",
year = "1989",
language = "English",
volume = "48",
pages = "447--454",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Publishing Group",
number = "6",

}

Swaak, AJG, Nossent, JC, Bronsveld, W, Van Rooyen, A, Nieuwenhuys, EJ, Theuns, L & Smeenk, RJT 1989, 'Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively' Annals of the Rheumatic Diseases, vol. 48, no. 6, pp. 447-454.

Systemic lupus erythematosus. I. Outcome and survival : Dutch experience with 110 patients studied prospectively. / Swaak, A. J G; Nossent, J. C.; Bronsveld, W.; Van Rooyen, A.; Nieuwenhuys, E. J.; Theuns, L.; Smeenk, R. J T.

In: Annals of the Rheumatic Diseases, Vol. 48, No. 6, 1989, p. 447-454.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Systemic lupus erythematosus. I. Outcome and survival

T2 - Dutch experience with 110 patients studied prospectively

AU - Swaak, A. J G

AU - Nossent, J. C.

AU - Bronsveld, W.

AU - Van Rooyen, A.

AU - Nieuwenhuys, E. J.

AU - Theuns, L.

AU - Smeenk, R. J T

PY - 1989

Y1 - 1989

N2 - This report presents an analysis of the cumulative survival in 110 well defined patients with systemic lupus erythematosus (SLE) who were followed up over a prolonged period of time. Special attention was paid to possible differences between patients who died and those who were still alive at the end of the study. Of the 110 patients with SLE, 96 (87%) were still alive after 10 years; the cumulative survival for men was 69% (11/16) and for women 90% (85/94). Patients who never developed a new exacerbation after the diagnosis for SLE had been established had a 10 year survival of 100%; for patients with one, two, or three exacerbations the 10 year survival was 91%, 69%, and 33% respectively. From these prospective studies it was found that the exacerbation frequency is most closely related to survival. Disease symptoms of renal involvement, or both, present at the onset or at the moment the SLE diagnosis was established, were predominantly seen in patients who died during the follow up.

AB - This report presents an analysis of the cumulative survival in 110 well defined patients with systemic lupus erythematosus (SLE) who were followed up over a prolonged period of time. Special attention was paid to possible differences between patients who died and those who were still alive at the end of the study. Of the 110 patients with SLE, 96 (87%) were still alive after 10 years; the cumulative survival for men was 69% (11/16) and for women 90% (85/94). Patients who never developed a new exacerbation after the diagnosis for SLE had been established had a 10 year survival of 100%; for patients with one, two, or three exacerbations the 10 year survival was 91%, 69%, and 33% respectively. From these prospective studies it was found that the exacerbation frequency is most closely related to survival. Disease symptoms of renal involvement, or both, present at the onset or at the moment the SLE diagnosis was established, were predominantly seen in patients who died during the follow up.

UR - http://www.scopus.com/inward/record.url?scp=0024380066&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 447

EP - 454

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -